BioPharma Dive 06.09.22 Resilience, a well-funded manufacturing startup, joins with the Parker Institute to make cancer drugs Read
San Francisco Business Times 06.08.22 Why these cancer immunotherapy experts are leaning into a five-year deal Read
The ASCO Post 06.07.22 Three-Arm First-Line Chemoimmunotherapy Study in Patients With Metastatic Pancreatic Cancer Read
HemOnc Today 12.02.21 Project aims to improve cancer cell therapies through gene expression profiling Read
Endpoints News 07.20.21 Sean Parker-backed cell therapy startup ArsenalBio plucks Merck VP as new CSO Read
Precision Oncology 06.15.21 NanoString Technologies, Parker Institute for Cancer Immunotherapy Partner on Cell Therapy Project Read
BioSpace 06.15.21 NanoString and Parker Institute for Cancer Immunotherapy Collaborate to Optimize Cell Therapies to Treat Cancer Read